Evidence map›Paper›PMID 38269269›Full record

ArticleFrontiers in pharmacology2023

Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19.

Brent J Tschirhart, Xiangru Lu, Aristide Laurel Mokale Kognou, Claudio M Martin, Marat Slessarev, Douglas D Fraser, Aleksandra Leligdowicz, Bradley Urquhart, Qingping Feng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Brent J TschirhartDepartment of Physiology and Pharmacology, Schulich School of Dentistry and Medicine, Western University, London, ON, Canada.
Xiangru LuDepartment of Physiology and Pharmacology, Schulich School of Dentistry and Medicine, Western University, London, ON, Canada.
Aristide Laurel Mokale KognouDepartment of Physiology and Pharmacology, Schulich School of Dentistry and Medicine, Western University, London, ON, Canada.
Claudio M MartinLawson Health Research Institute, London Health Sciences Centre, London, ON, Canada.
Marat SlessarevLawson Health Research Institute, London Health Sciences Centre, London, ON, Canada.
Douglas D FraserLawson Health Research Institute, London Health Sciences Centre, London, ON, Canada.
Aleksandra LeligdowiczDivision of Critical Care, Department of Medicine, Schulich School of Dentistry and Medicine, Western University, London, ON, Canada.
Bradley UrquhartDepartment of Physiology and Pharmacology, Schulich School of Dentistry and Medicine, Western University, London, ON, Canada.
Qingping FengDepartment of Physiology and Pharmacology, Schulich School of Dentistry and Medicine, Western University, London, ON, Canada.
London Health Sciences Centre · CAWestern University · CALawson Health Research Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

annexin A5COVID-19pharmacokineticssepsisSY-005

Identifiers

PMID38269269
PMCPMC10806122
OpenAlexW4390698657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.